Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.

Burch, P A

Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial. [electronic resource] - American journal of clinical oncology Oct 2000 - 534-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.

0277-3732

10.1097/00000421-200010000-00021 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Dipyridamole--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Leucovorin--administration & dosage
Male
Middle Aged
Mitomycin--administration & dosage
Pancreatic Neoplasms--drug therapy
Survival Analysis
Treatment Failure